About Bioline  All Journals  Testimonials  Membership  News  Donations

Middle East Fertility Society Journal
Middle East Fertility Society
ISSN: 1110-5690
Vol. 9, No. 2, 2004, pp. 101-106
Bioline Code: mf04018
Full paper language: English
Document type: Research Article
Document available free of charge

Middle East Fertility Society Journal, Vol. 9, No. 2, 2004, pp. 101-106

 en OPINION- Intrauterine insemination
Aboubakr M. Elnashar


Stimulated intrauterine insemination (IUI) should be the first choice treatment for mild male factor infertility, unexplained infertility or minimal to mild endometriosis. In mild male factor infertility, unexplained infertility, IUI is as effective as IVF & at 1/3 of the cost per pregnancy. In couples with the most severe semen defects, IUI in natural cycle should be the treatment of choice. In mild to moderate semen defects, mild ovarian hyperstimulation with IUI is recommended. In endometriosis, simplified ultrlong protocol with IUI gives better chances of achieving pregnancy. Ultrasonographic monitoring & human chorionic gonadotropin (hCG) induction of ovulation does not produce an increased pregnancy rate over urinary lutenising hormone (LH) monitoring of ovulation. Double IUI showed no significant benefit over single IUI. Four cycles of IUI are enough. Continued IUI is not recommended.

intrauterine insemination, infertility

© Copyright 2004 - Middle East Fertility Society
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2020, Site last up-dated on 06-Apr-2020.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil